US stocks started off 2021 with a massive downturn on Monday, after ending the previous year on a strong note. Markets turned higher after the slump on prospects of higher government aid with the Democrats winning the Senate race in Georgia. The Congress also confirmed Joe Biden’s win as the US President last week a
US stocks closed higher on the last trading day of the week, also wrapping a year in which the markets went through a rollercoaster ride. Wall Street plummeted sharply in February and March with the coronavirus outbreak spreading outside China, which forced several countries to impose lockdown restrictions, bringing economic activity to a grinding halt.
US stocks started the holiday-shortened week on a mixed note, with traders monitoring news of a new variant of coronavirus detected in the UK. Meanwhile, investors also welcomed news of lawmakers agreeing to a $900 billion covid-19 aid package. Markets became cautious, however, after President Donald Trump raised concerns about the package, calling it “a disgrace” and
Wall Street climbed to record highs last week despite starting the week on a negative note. Hopes of US lawmakers passing the covid-19 relief bill and another pharma giant receiving FDA clearance for its vaccine candidate spurred optimism among investors. Capitol Hill leaders said they were close to reaching a deal to provide an additional
US markets started the week on a lower note with investors still waiting for US lawmakers to announce the new stimulus package. The week ended without any agreement reached around the covid-19 relief package, while the government is eager to pass a bill before yearend. Meanwhile, Britain began its covid-19 mass vaccination program last week,
Last week started on a downbeat note for Wall Street, after stocks finished November with historic gains, with the Dow recording its strongest monthly surge since 1987. The week progressed with positive news related to the coronavirus vaccine being approved by the UK, following the completion of late-stage trials. Pfizer and its German partner BioNTech
Last week started with another encouraging announcement for a covid-19 vaccine after Moderna said that its candidate was 94.5% effective in Phase 3 trials. The update came just a week after Pfizer’s vaccine candidate, developed in partnership with BioNTech, delivered 90% efficacy. Pfizer managed to stay ahead of Moderna by reporting strong results from the
Wall Street started the week on a strong note as investors cheered news of encouraging data from late-stage trials of the covid-19 vaccine candidate being developed by Pfizer and BioNTech. The companies disclosed that their vaccine candidate is more than 90% effective in treating patients suffering from coronavirus. The companies also signed deals with various countries for
US stocks started the election week with a bang, as investors looked forward to the end of uncertainty. As the week progressed, Democratic party nominee Joe Biden consolidated his lead, and the Republicans took control of the Senate. The markets responded positively to the developments; even as incumbent President Donald Trump tried to disrupt the
Wall Street started the week with massive losses as coronavirus cases spiked in the US and Europe. Investor sentiment remained tepid as various European countries reinforced lockdown measures, fueling concerns over a slowdown in the rebound of the global economy. The week also ended on a downbeat note with major tech companies reporting earnings after
